US20150107195A1 - Container and Method of Manufacture of Container - Google Patents

Container and Method of Manufacture of Container Download PDF

Info

Publication number
US20150107195A1
US20150107195A1 US14/119,280 US201114119280A US2015107195A1 US 20150107195 A1 US20150107195 A1 US 20150107195A1 US 201114119280 A US201114119280 A US 201114119280A US 2015107195 A1 US2015107195 A1 US 2015107195A1
Authority
US
United States
Prior art keywords
closure
container
piston
active agents
recess
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/119,280
Other languages
English (en)
Inventor
Spyridon Edouard Tsakas
Spyridon Christos Tsakas
Original Assignee
Eulysis Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eulysis Uk Limited filed Critical Eulysis Uk Limited
Publication of US20150107195A1 publication Critical patent/US20150107195A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1412Containers with closing means, e.g. caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • A61J1/2072Venting means for internal venting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B29/00Packaging of materials presenting special problems
    • B65B29/10Packaging two or more different substances isolated from one another in the package but capable of being mixed without opening the package, e.g. forming packages containing a resin and hardener isolated by a frangible partition
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02Sterilising, e.g. of complete packages
    • B65B55/04Sterilising wrappers or receptacles prior to, or during, packaging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/08Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00Closing containers or receptacles after filling
    • B65B7/16Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B65B7/28Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/24Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/241Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes provided with freeze-drying means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/24Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • B65D51/2807Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
    • B65D51/2814Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it

Definitions

  • Methods of manufacturing sterile liquid containers and sterile liquid containers more specifically methods of manufacturing vials and vials.
  • the one or more active agents is an unstable species in solution
  • the one or more active agents and the diluent are often stored separately in two sterile storage units before administration.
  • the one or more active agents and the diluent are stored separately and combined immediately prior to administration, there is a risk of contamination of the medicament. To ensure that contamination does not occur, the combination of the one or more active agents and diluent is carried out using a lengthy and time consuming procedure.
  • a method of manufacturing a pre-loaded container for use in dispensing one or more active agents comprising the steps of;
  • the step of sealing the closure comprises sealedly mounting a sealing element comprising a piston.
  • the piston may comprise a hollow column retained within a cylinder in the closure.
  • the piston may comprise apertures suitable for ventilating the recess of the closure during the step of lyophilisation.
  • the step of sealing the closure may seal the apertures of the piston.
  • the piston may comprise a deformable feature extending from the outer surface of the closure such that deformation of the piston by the application of pressure to the said outer surface releases the lyophilised one or more active agents from the closure into the diluent of the container.
  • lyophilised active agent and diluent are stored in separate sterile containers. Therefore, for any one active agent to be available for use, two components must be sourced and stored.
  • the active agent is to be used, the diluent is extracted from its packaging using a syringe and the syringe is then inserted into the packaging of the active agent. The diluent is then added to solubilise the active agent.
  • the active agent packaging must then be agitated to ensure that the active agent is fully dissolved to reconstitute the active agent into its solubilised form. Finally, the solution is then drawn into the syringe ready for use.
  • container made according to the above method allows the active agent and diluent to be stored as a single entity, conserving space.
  • the process of reconstituting the active agent is greatly reduced to a two step process of breaking the closure to allow the lyophilised active agent to fall into the diluent and then agitating the vial to ensure the lyophilised one or more active agents are fully reconstituted, thereby ensuring that there is no risk of contamination and that the solubilised one or more active agents can be rendered ready for use much faster than convention methods.
  • the provision of a container storing both the lyophilised active agent and the diluent required to reconstitute the active agent results in less packaging being required to be manufactured and produces less waste when the container is to be disgarded.
  • the steps of adding the diluent to the container and sealing the container with the closure may be carried out before or after the steps of adding a portion of the solution into the recess of the closure, lyophilising the solution in the recess of the closure and sealing the closure.
  • the container may be a vial.
  • the closure may be a vial cap.
  • the closure is sterilised before the step of adding the solution to it.
  • the interior of the container and the interior of the closure are sterile after the container is sealed to the closure.
  • a sterilised closure ensures that the one or more active agents are not contaminated before the lyophilisation process and therefore that the lyophilised one or more active agents will be contaminant free. Ensuring that the interior of the container and the interior of the closure are sterile after the container is sealed to the closure allows the user to be confident that the diluent and the lyophilised one or more active agents are contaminant free and the resultant solubilised one or more active agents are safe to use, especially important in embodiments where the one or more active agents are a vaccine, for example.
  • the one or more active agents may be a biologically active species, such as artificially expressed or reconstituted proteins, nucleic acid sequences or their mixtures.
  • the one or more active agents may be medically active agents, such as a vaccine, for example.
  • the diluent is typically an aqueous solution.
  • the diluent may be saline solution, for example.
  • the method of the present aspect of the invention may be used to store proteins expressed in a laboratory or to store the one or more active agents of a medicament for transportation from the manufacturer to the site where it will be administered, for example.
  • the closure immediately preceding the step of lyophilising the solution in the closure, the closure is covered.
  • the closure may be covered by the sealing element comprising a piston and the piston may define at least one aperture to allow the recess of the closure to be ventilated during the step of lyophilisation.
  • the step of sealedly mounting the sealing element to the closure may seal the at least one aperture, thereby sealing the recess of the closure.
  • the closure may be covered by a cover comprising a material that is permeable to the solvent of the active agent solution, such that during lyophilisation the solvent may sublime into the applied vacuum.
  • the closure may comprise a frangible member.
  • the solution lyophilised within the recess of the closure may be in contact with the frangible member such that the lyophilised one or more active agents is in contact with the frangible member.
  • the piston of the sealing element may be moved from a first position to a second position so that in the second position the piston breaks and extends beyond the frangible member such that the lyophilised one or more active agents is combined with the diluent.
  • the piston of the sealing element is manually operable between the first position and the second position.
  • a pre-loaded container comprising a container body and a closure; the closure having a recess, a frangible member and a piston arranged adjacent to the frangible member; the container body retaining a diluent and the closure recess retaining one or more active agents lyophilised within the closure by the method of the first aspect of the invention; wherein the piston of the closure may be moved from a first position to a second position so that in the second position the piston breaks and extends beyond the frangible member such that the lyophilised one or more active agent is combined with the diluent.
  • the piston may be part of a sealing element sealedly mounted to the closure.
  • a pre-loaded container allows the one or more active agents that have been lyophilised within the cap of the vial and the diluent to be stored in the same sterile environment within which mixing and solubilisation of the one or more active agents will occur.
  • the piston of the closure is manually operable between the first position and the second position.
  • the portion of the piston forming an outer surface of the closure may comprise an air tight permeable or semi-permeable material such that a needle may penetrate the outer surface to extract the reconstituted active agent, but ensure that the lyophilised one or more active agents remain sterile and sealed within the closure.
  • the piston may move from a first position to a second position such that the piston displaces a floor element of the frangible member of the closure, thereby allowing the lyophilised one or more active agents resting on the said floor element to fall into the diluent in the vial.
  • the floor element may be pivotally mounted to the vial cap such that the movement of the piston results in the floor element being moved from a horizontal orientation to a vertical orientation and the lyophilised one or more active agents falls into the diluent.
  • the lyophilised one or more active agents are compressed into a cake or tablet for efficient storage.
  • the closure recess may retain a cake or tablet of lyophilised active agent such that when the piston is moved from the first position to the second position the cake or tablet of lyophilised active agent is combined with the diluent.
  • the cake or tablet of lyophilised active agent may comprise a single active agent.
  • the cake or tablet of lyophilised active agent may comprise more than one active agent.
  • the cake or tablet of lyophilised active agent may comprise a different active agent to the active agent lyophilised within the closure.
  • FIG. 1 is a side view of a pre-loaded vial (a) as stored and (b) after the one or more active agents have been applied to the diluent;
  • FIG. 2 is a scheme of the method of manufacture of a pre-loaded vial.
  • a pre-loaded vial 1 comprises a vial (acting as a container) 2 and a vial cap 4 (acting as a closure).
  • the vial cap comprises a piston 6 , a base 8 (acting as a frangible member) and a recess 10 retaining a lyophilised vaccine 12 (acting as an active agent).
  • the vial retains a diluent 14 (for example, saline solution) suitable for solubilising the lyophilised vaccine.
  • the piston of the vial cap defines apertures, which are sealed after manufacture.
  • the pre-loaded vial is manufactured by the following method, shown in FIG. 2 .
  • the vial and vial cap are sterilised.
  • a solution of the vaccine is prepared and one dose of the vaccine is placed into the recess of the vial cap.
  • the recess of the vial cap is then covered by the piston.
  • the apertures defined by the piston allow the recess of the vial cap to be ventilated.
  • the vaccine solution within the vial cap is then lyophilised. That is, the vaccine solution is frozen and then warmed in vacuum to allow solvent in the vial cap to sublime into the vacuum through the apertures defined by the piston, leaving the vaccine protein behind in the vial cap.
  • the advantage of lyophilisation is that the vaccine protein left behind in the vial cap is not structurally altered and is much more stable than the solubilised vaccine.
  • the vial cap is then sealed such that the apertures of the piston are sealed and the recess of the vial cap is sealed to ensure that the lyophilised vaccine retained within the recess remains sterile.
  • the diluent is added to the vial.
  • the vial cap is then sealed to the vial such that the diluent within the vial is sealed from the outside and that the lyophilised vaccine is sealed from the diluent in the vial and the outside, thereby ensuring that the diluent and vaccine are retained in sterile conditions.
  • a pre-loaded vial prepared by the above method may then be stored within a refrigerator or according to its recommended storage conditions to await use.
  • the piston of the vial cap is pressed by the user (a) such that the piston moves through and extends beyond the base of the vial cap, thereby breaking the said base and allowing the lyophilised vaccine to fall into the diluent within the vial (b).
  • the vial is then agitated to ensure that the vaccine is fully solubilised.
  • the vaccine is then ready for use, and may be extracted by piercing the seal of the piston of the vial cap with a syringe and drawing the newly solubilised vaccine into the syringe after sterilisation of the outer surface of the vial cap.
  • a lyophilised biologic may be stored in the pre-loaded vial using the method of the present invention for storage within a refrigerator or according to its recommended storage conditions.
  • the piston may move from a first position to a second position such that the piston displaces the base of the vial, thereby allowing the lyophilised active agent resting on the said base to fall into the diluent in the vial.
  • the base may be hinged such that the base is moved from a horizontal orientation to a vertical orientation such that the lyophilised active agent falls into the diluent.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Closures For Containers (AREA)
US14/119,280 2011-08-22 2011-12-09 Container and Method of Manufacture of Container Abandoned US20150107195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1114432.6 2011-08-22
GB201114432A GB2485254C (en) 2011-08-22 2011-08-22 A container having a recessed closure for drying and storing one or more active agents
PCT/GB2011/052453 WO2013026995A1 (fr) 2011-08-22 2011-12-09 Récipient et procédé de fabrication de récipient

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2011/052453 A-371-Of-International WO2013026995A1 (fr) 2011-08-22 2011-12-09 Récipient et procédé de fabrication de récipient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/439,722 Continuation US20170224586A1 (en) 2011-08-22 2017-02-22 Container and method of manufacture of container

Publications (1)

Publication Number Publication Date
US20150107195A1 true US20150107195A1 (en) 2015-04-23

Family

ID=44800654

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/119,280 Abandoned US20150107195A1 (en) 2011-08-22 2011-12-09 Container and Method of Manufacture of Container
US15/439,722 Abandoned US20170224586A1 (en) 2011-08-22 2017-02-22 Container and method of manufacture of container

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/439,722 Abandoned US20170224586A1 (en) 2011-08-22 2017-02-22 Container and method of manufacture of container

Country Status (3)

Country Link
US (2) US20150107195A1 (fr)
GB (1) GB2485254C (fr)
WO (1) WO2013026995A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109195A1 (fr) * 2018-11-26 2020-06-04 F. Hoffmann-La Roche Ag Fabrication d'un contenant souple
WO2020109194A1 (fr) * 2018-11-26 2020-06-04 F. Hoffmann-La Roche Ag Récipient de lyophilisat et kit de perfusion
CN111885990A (zh) * 2018-01-05 2020-11-03 太平洋有限公司 方法和装置

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201415869D0 (en) * 2014-09-08 2014-10-22 Eulysis Uk Ltd Container And Closure
EP3695823A4 (fr) * 2017-10-10 2021-10-13 Seikagaku Corporation Récipient de stockage de médicament, élément de fermeture, procédé de fabrication d'un récipient de stockage de médicament, procédé d'inspection de micro-organismes et de contaminants, et préparation solide pour préparation de solution tampon

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3603469A (en) * 1968-04-11 1971-09-07 Ambrogio Magni Guarantee cap
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
US4601704A (en) * 1983-10-27 1986-07-22 Abbott Laboratories Container mixing system with externally mounted drug container
US4793475A (en) * 1985-01-26 1988-12-27 Celamerck Gmbh & Co. Kg Closure caps for two-component packaging systems
US5320603A (en) * 1991-08-21 1994-06-14 Arzneimitel Gmbh Apotheker Vetter & Co. Hypodermic syringe for lyophilized medicament
US5522155A (en) * 1994-08-19 1996-06-04 W. L. Gore & Associates, Inc. Vented vial method of minimizing contamination of freeze-dried products
US5533994A (en) * 1988-12-27 1996-07-09 Becton Dickinson France S.A. Storage and transfer bottle designed for storing two components of a medicamental substance
US5641010A (en) * 1994-07-14 1997-06-24 International Medication Systems, Limited Mixing and dispensing apparatus
US6786330B2 (en) * 1997-10-14 2004-09-07 Biogaia Ab Two-compartment container
US6840373B2 (en) * 2002-05-16 2005-01-11 Gregory A Gibler Beverage storage and discharge cap assembly
US6921087B2 (en) * 2002-08-20 2005-07-26 Nippon Tansan Gas Co., Ltd. Sealing mechanism for vessel and cap to be used in the mechanism
US20050211579A1 (en) * 2004-03-29 2005-09-29 Masayuki Makita And Bzi Co., Ltd. Bottle cap
US7325676B2 (en) * 2003-07-11 2008-02-05 Jose Luis Galaz Rodriguez Container for containing two different separate products and mixing them
US7473399B2 (en) * 2003-05-22 2009-01-06 Agilent Technologies, Inc. Dispensing volumes of liquids using a flap septum
US20090139951A1 (en) * 2007-10-25 2009-06-04 The Sunrider Corporation D.B.A. Sunrider International Safety sealed reservoir cap
US7748550B2 (en) * 2004-11-23 2010-07-06 Young Kook Cho Sanitary double cap allowing addition of adjunct to contents of a container
US8418865B2 (en) * 2003-11-28 2013-04-16 Young-Kook Cho Bottle having two separated spaces in a bottle body

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441179A (en) * 1967-05-29 1969-04-29 Ways & Means Inc Mixing container
US3578195A (en) * 1969-01-16 1971-05-11 Lyoflo Stopper Corp Lyoflo-stopper
US3802604A (en) * 1972-02-28 1974-04-09 Oreal Device for storing two products separately and dispensing them simultaneously
US3881626A (en) * 1972-11-20 1975-05-06 Warner Lambert Co Container closure for lyophilized products
US3834571A (en) * 1972-11-20 1974-09-10 Warner Lambert Co Container closure for lyophilized products
US4060911A (en) * 1975-08-07 1977-12-06 Behringwerke Aktiengesellschaft Process for the preparation of a container closed under sterile conditions and containing lyophilized material
US4084330A (en) * 1976-07-02 1978-04-18 Fts Systems, Inc. Flask for freeze drying with adjustable seal
US4089432A (en) * 1977-05-06 1978-05-16 The Upjohn Company Vial and closure
US4172457A (en) * 1977-10-06 1979-10-30 American Hospital Supply Corporation Plural component mixing system and method
US4550825A (en) * 1983-07-27 1985-11-05 The West Company Multicompartment medicament container
US4727985A (en) * 1986-02-24 1988-03-01 The Boc Group, Inc. Mixing and dispensing apparatus
US5303835A (en) * 1992-06-24 1994-04-19 Habley Medical Technology Corporation Lyophilization cap and method
US5447374A (en) * 1994-01-03 1995-09-05 Fts Systems, Inc. Positioning device for temperature sensor in freeze drying
ATE283346T1 (de) * 1995-09-22 2004-12-15 Us Gov Health & Human Serv Gefäss zur trocknung von biologischer proben, verfahren zur herstellung desselben und verfahren zu seinem gebrauch
US5596814A (en) * 1995-11-06 1997-01-28 W. L. Gore & Associates, Inc. Vented vial stopper for processing freeze-dried products
JPH09278051A (ja) * 1996-04-09 1997-10-28 Taisei Kako Kk ロック機構付き冠状蓋
FI102642B1 (fi) * 1996-06-19 1999-01-15 Orion Yhtymae Oyj Reaktioastian tai vastaavan tulppa
US6199297B1 (en) * 1999-02-01 2001-03-13 Integrated Biosystems, Inc. Lyophilization apparatus and methods
EP1243245A4 (fr) * 1999-09-30 2006-10-18 Astellas Pharma Inc Contenant pour perfusion et procede de stockage d'un medicament lyophilise
AU2003245635A1 (en) * 2002-06-25 2004-01-06 Creare Incorporated Mixing vial
US20050086830A1 (en) * 2003-10-24 2005-04-28 Zukor Kenneth S. Processing cap assembly for isolating contents of a container
US20090158612A1 (en) * 2004-10-27 2009-06-25 Jacques Thilly Process for preparing a lyophilised material
DE102005038368A1 (de) * 2005-08-13 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Doppelkammer-Behälter zur Lyophilisation, Verfahren zu dessen Befüllung und dessen Verwendung
CN201436243U (zh) * 2007-12-20 2010-04-07 仙妮蕾德公司 安全密封的贮存室盖
FR2927316B1 (fr) * 2008-02-11 2010-05-14 Biocorp Rech Et Dev Dispositif de bouchage a chapeau d'appui et recipient equipe d'un tel dispositif
BRPI0917490A2 (pt) * 2008-08-11 2015-12-01 Astrazeneca Ab suplemento de recipiente pre-carregado para misturar dois ou mais ingredientes para usop em um sistema de recipiente farmaceutico
FR2950035B1 (fr) * 2009-09-15 2011-09-02 Raymond A & Cie Coiffe de verrouillage pour recipient a col
FR2950865B1 (fr) * 2009-10-01 2011-10-28 Raymond A & Cie Coiffe de verrouillage pour recipient a col avec une capsule a pattes de fixation
FR2967655B1 (fr) * 2010-11-24 2014-03-14 Biocorp Rech Et Dev Dispositif de bouchage d'un recipient, recipient equipe d'un tel dispositif et procede de fermeture d'un lot de tels recipients

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3603469A (en) * 1968-04-11 1971-09-07 Ambrogio Magni Guarantee cap
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
US4031892A (en) * 1974-07-18 1977-06-28 Ampoules Corporation Two-chamber mixing syringe
US4601704A (en) * 1983-10-27 1986-07-22 Abbott Laboratories Container mixing system with externally mounted drug container
US4793475A (en) * 1985-01-26 1988-12-27 Celamerck Gmbh & Co. Kg Closure caps for two-component packaging systems
US5533994A (en) * 1988-12-27 1996-07-09 Becton Dickinson France S.A. Storage and transfer bottle designed for storing two components of a medicamental substance
US5320603A (en) * 1991-08-21 1994-06-14 Arzneimitel Gmbh Apotheker Vetter & Co. Hypodermic syringe for lyophilized medicament
US5641010A (en) * 1994-07-14 1997-06-24 International Medication Systems, Limited Mixing and dispensing apparatus
US5522155A (en) * 1994-08-19 1996-06-04 W. L. Gore & Associates, Inc. Vented vial method of minimizing contamination of freeze-dried products
US6786330B2 (en) * 1997-10-14 2004-09-07 Biogaia Ab Two-compartment container
US6840373B2 (en) * 2002-05-16 2005-01-11 Gregory A Gibler Beverage storage and discharge cap assembly
US6921087B2 (en) * 2002-08-20 2005-07-26 Nippon Tansan Gas Co., Ltd. Sealing mechanism for vessel and cap to be used in the mechanism
US7473399B2 (en) * 2003-05-22 2009-01-06 Agilent Technologies, Inc. Dispensing volumes of liquids using a flap septum
US7325676B2 (en) * 2003-07-11 2008-02-05 Jose Luis Galaz Rodriguez Container for containing two different separate products and mixing them
US8418865B2 (en) * 2003-11-28 2013-04-16 Young-Kook Cho Bottle having two separated spaces in a bottle body
US20050211579A1 (en) * 2004-03-29 2005-09-29 Masayuki Makita And Bzi Co., Ltd. Bottle cap
US7748550B2 (en) * 2004-11-23 2010-07-06 Young Kook Cho Sanitary double cap allowing addition of adjunct to contents of a container
US20090139951A1 (en) * 2007-10-25 2009-06-04 The Sunrider Corporation D.B.A. Sunrider International Safety sealed reservoir cap

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111885990A (zh) * 2018-01-05 2020-11-03 太平洋有限公司 方法和装置
WO2020109195A1 (fr) * 2018-11-26 2020-06-04 F. Hoffmann-La Roche Ag Fabrication d'un contenant souple
WO2020109194A1 (fr) * 2018-11-26 2020-06-04 F. Hoffmann-La Roche Ag Récipient de lyophilisat et kit de perfusion
CN113164322A (zh) * 2018-11-26 2021-07-23 豪夫迈·罗氏有限公司 冻干物容器和输注套件
US11952155B2 (en) 2018-11-26 2024-04-09 Hoffmann-La Roche Inc. Manufacturing a flexible container

Also Published As

Publication number Publication date
WO2013026995A1 (fr) 2013-02-28
GB201114432D0 (en) 2011-10-05
GB2485254B (en) 2013-01-23
US20170224586A1 (en) 2017-08-10
GB2485254A (en) 2012-05-09
GB2485254C (en) 2013-12-25

Similar Documents

Publication Publication Date Title
US20170224586A1 (en) Container and method of manufacture of container
US11246802B2 (en) Container and closure
JP6223999B2 (ja) 固体タンパク質組成物を迅速に溶解させるための方法及び装置
JP4749328B2 (ja) 活性因子を凍結乾燥するための方法
JP4638553B1 (ja) 二室式容器兼用注射器の製造方法及びフロントストッパー
US20150041498A1 (en) Device for accommodating a freeze-dried pharmaceutical product and method of manufacturing a sealed vessel accommodating a freeze-dried pharmaceutical product
JP6985141B2 (ja) 流体薬剤成分を混合及び分注するための容器
JPH11512014A (ja) 薬剤変換装置
US9022995B2 (en) Stopper/plunger for carpules of syringe-carpule assembly
JP4536825B1 (ja) 二室式容器兼用注射器の製造方法及び製剤入りスリーブ
JP2018500126A (ja) 構成成分を混合及び分注するための容器
US20160158716A1 (en) Novel reconstitution assembly
JP2018042997A (ja) 凍結乾燥機械用のチャンバ
ES2836828T3 (es) Equipo para producir una vacuna
CN201061615Y (zh) 一种装有注射液的安瓿

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION